ALX Oncology Inc. (ALXO)
NASDAQ: ALXO
· Real-Time Price · USD
0.44
-0.02 (-4.22%)
At close: May 15, 2025, 3:59 PM
0.44
0.27%
After-hours: May 15, 2025, 04:19 PM EDT
-4.22% (1D)
| Bid | 0.42 |
| Market Cap | 23.46M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -130.02M |
| EPS (ttm) | -2.45 |
| PE Ratio (ttm) | -0.18 |
| Forward PE | -0.33 |
| Analyst | Buy |
| Ask | 0.5 |
| Volume | 324,552 |
| Avg. Volume (20D) | 797,703 |
| Open | 0.46 |
| Previous Close | 0.46 |
| Day's Range | 0.43 - 0.47 |
| 52-Week Range | 0.41 - 15.35 |
| Beta | 1.21 |
About ALXO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALXO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALXO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-19.08%
ALX Oncology Holdings shares are trading lower. Th...
Unlock content with
Pro Subscription
2 months ago
+25.96%
ALX Oncology Holdings shares are trading higher after Piper Sandler and Jefferies upgraded their respective price targets on the stock.
